WHO Identifies Six Candidates for Dengue Drug Development

The World Health Organization (WHO) has narrowed its focus to six potential drug candidates for treating dengue fever.

Currently, only one of these candidates has progressed to late-stage clinical trials, marking a critical phase in the global effort to combat the disease.

With dengue outbreaks rising in various regions, the development of an effective antiviral treatment remains a top priority for international health agencies.